NIA Impact Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
NIA Impact Advisors's GILD Position: Q2 2026 in Review
NIA Impact Advisors reduced its Gilead Sciences (GILD) stake by 0.26% in Q2 2026, selling an estimated $16.7K and leaving 49,515 shares worth $6.26M. The position accounts for 2.59% of the portfolio, ranked #12.
NIA Impact Advisors first reported a position in GILD in Q4 2020 and has held it in 21 quarters since. The position peaked at $7.01M in Q4 2022. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- NIA Impact Advisors held 49,515 shares of Gilead Sciences worth $6.26M as of Q2 2026.
- NIA Impact Advisors sold 127 Gilead Sciences shares in Q2 2026, an estimated $16.7K.
- Gilead Sciences made up 2.59% of NIA Impact Advisors's portfolio in Q2 2026, its #12 holding.
- NIA Impact Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 21 quarters since.
- NIA Impact Advisors's Gilead Sciences position peaked at $7.01M in Q4 2022.
- 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on NIA Impact Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.